Imugene Limited
Clinical trials sponsored by Imugene Limited, explained in plain language.
-
Virus therapy tested to fight tough cancers
Disease control TerminatedThis early-stage study tested the safety of a new treatment called CF33-CD19, a modified virus designed to attack cancer cells. It was given alone or combined with another immunotherapy drug (blinatumomab) to adults with advanced solid tumors that had stopped responding to at lea…
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Cancer-Fighting virus tested in patients with advanced tumors
Disease control TerminatedThis early-stage study tested the safety of an experimental treatment called VAXINIA, which is a modified virus designed to infect and kill cancer cells. It was given to 66 adults with advanced solid tumors that had spread and stopped responding to other treatments. The virus was…
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Vaccine-Style treatment tested for tough lung cancers
Disease control TerminatedThis early-stage study tested a new immunotherapy called IMU-201 (PD1-Vaxx) for adults with advanced non-small cell lung cancer. The main goals were to find a safe dose and see if the treatment could help the immune system fight the cancer. The study was small and ended early, so…
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC